Financials Quoin Pharmaceuticals, Ltd.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 15/07/2025 BST			5-day change	1st Jan Change
8.785 ^USD	-2.93%		-1.07%	-61.43%

07-08	Quoin Pharmaceuticals & CFO Gordon Dunn agree to a mutual separation	RE
07-08	Quoin Pharmaceuticals Ltd. Announces Mutual Separation with CFO Gordon Dunn	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	-	-	-	-	-	-	6.528	56.97
Change	-	-	-	-	-	-	-	772.76%
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	-	-6.063	-9.258	-9.378	-9.528	-16.5	-9.51	28.18
Change	-	-	-52.7%	-1.3%	-1.6%	-73.21%	42.38%	396.31%
Interest Paid	-	-1.09	-0.7141	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-21.46	-9.382	-8.687	-8.962	-10.88	-10.52	-1.699
Change	-	-	56.29%	7.41%	-3.18%	-21.41%	3.35%	83.85%
Net income ¹	-2.095	-21.46	-9.447	-8.687	-8.962	-16.05	-10.52	-1.699
Change	-	-924.29%	55.98%	8.05%	-3.18%	-79.04%	34.46%	83.85%
Announcement Date	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-1.303	-2.981	-2.176	-2.668	-2.328	-2.086	-2.776	-2.26	-2.125	-2.218	-	-2.137	-2.528	-2.405	-3.957	-4.119	-4.194	-4.234
Change	-	-128.85%	27.01%	-22.62%	12.77%	10.38%	-33.06%	18.57%	5.97%	-4.35%	-	-	-18.29%	4.86%	-64.54%	-4.08%	-1.84%	-0.94%
Charge d'intérêts	-0.2482	-0.5741	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-11.82	-1.683	-2.668	-3.03	-2.001	-2.603	-2.107	-1.927	-2.05	-	-1.974	-2.35	-2.311	-3.812	-2.597	-2.833	-3.019
Change	-	-	85.76%	-58.56%	-13.54%	33.95%	-30.09%	19.06%	8.56%	-6.39%	-	-	-19.04%	1.64%	-64.94%	31.88%	-9.09%	-6.57%
Net income ¹	-1.404	-11.82	-1.683	-2.668	-3.095	-2.001	-2.603	-2.107	-1.927	-2.05	-	-1.974	-2.35	-2.311	-3.812	-4.013	-4.088	-4.134
Change	-	-741.59%	85.76%	-58.56%	-15.99%	35.35%	-30.09%	19.06%	8.56%	-6.39%	-	-	-19.04%	1.64%	-64.94%	-5.26%	-1.87%	-1.13%
Announcement Date	20/12/21	14/04/22	23/05/22	18/08/22	10/11/22	09/03/23	09/05/23	03/08/23	09/11/23	13/03/24	09/05/24	08/08/24	08/11/24	13/03/25	13/05/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-

Estimates

Fiscal Period: December	2021	2022	2023	2024
CAPEX ¹	-	-	-	-
Change	-	-	-	-
Free Cash Flow (FCF) ¹	-3.583	-6.214	-4.684	-4.275
Change	-	-73.41%	24.62%	8.73%
Announcement Date	14/04/22	15/03/23	14/03/24	13/03/25

¹USD in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-145.68%	49.46%
EBT Margin (%)	-	-	-	-	-	-	-	-161.12%	-2.98%
Net margin (%)	-	-	-	-	-	-	-	-161.12%	-2.98%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	21.57%	-	-	-	-	-	-
Profitability
ROA	-	-87.18%	-70.6%	-48.59%	-44.03%	-42.72%	-	-	-
ROE	-	37.69%	721.4%	-232.68%	-132.92%	-120.55%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-0.57x	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-11,025	-28,455	-1,638	-337.4	-66.85	-27.3	-15.75	-2.45
Change	-	-	-158.1%	94.24%	79.4%	80.19%	59.16%	42.31%	84.44%
Nbr of stocks (in thousands)	-	-	1.59	11.5	28.2	234	588.2	588.2	588.2
Announcement Date	-	16/06/21	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-